RE:RE:RE:RE:Low Volume + High Share Controlwhy do you think that the company valued Dialco at only 60 cents in their December presentation? Cuz, in the absence of general market awareness, Analyst coverage, etc. especially south of the border, they need to discount it, in order to incentize early takers to offset perceived "risk".
why do you think that the recent clinic DIMI FDA approval and recent IDE approval have been so damaging to the share price? The market is highly inefficient for Cdn small caps off the US radar. the news wasn't damaging, it just didn't resonate where it counts, IMO
do you think that there will be more valuation integrity in the share price as Dr Kellum gets acquainted with his role? Hopefully. He lends major credibilty, likely has key connections, opens doors...and a few other things.